Drug Trial Radar · NCT07899996
A Study of HB0056 in Adult Participants With Moderate to Severe Asthma
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Aug 21, 2025
Primary completion
Aug 1, 2027
Study completion Aug 1, 2028
Sponsor
- Lead sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if drug HB0056 works to treat severe asthma in adults. It will also learn about the safety of drugHB0056. The main questions it aims to answer are: Does drug HB0056 lower the number of times participants need to use a rescue inhaler? What medical problems do participants have when taking drug HB0056? Researchers will compare drug HB0056 to a placebo to see if drug HB0056 works to treat severe asthma. Participants will: Take drug HB0056 or a placebo Q2W. Keep a diary of their symptoms and the number of times they use a rescue inhaler
Conditions
- Asthma
Interventions
PlaceboDrug
Placebo
HB0056Drug
Targeting TSLP and IL-11 IgG1-type Bispecific Antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part I(Phase Ib): AEsTime frame: From baseline to week 16
- Part I (Phase Ib): Tss_maxTime frame: From baseline to week 16
- Part II (Phase II): Change from baseline in pre-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)Time frame: From baseline to week 12
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
China-Japan Friendship Hospital
Beijing, China · Recruiting
China-Japan Friendship Hospital
Beijing, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.